# Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

> **NCT07480161** · PHASE2,PHASE3 · RECRUITING · sponsor: **Ankara City Hospital Bilkent** · enrollment: 90 (estimated)

## Conditions studied

- Erectile Dysfunction With Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** Umbilical Cord-Derived Mesenchymal Stem Cells
- **BIOLOGICAL:** Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes
- **BIOLOGICAL:** Placebo Intracavernosal Injection

## Key facts

- **NCT ID:** NCT07480161
- **Lead sponsor:** Ankara City Hospital Bilkent
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-29
- **Primary completion:** 2027-12-29
- **Final completion:** 2028-12-29
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07480161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07480161, "Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07480161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*